Vulva

Primary Site Histology
C510-C512, C518-C519 8000-8040, 8042-8180, 8191-8246, 8248-8700, 9020, 9071

Notes

8000-8040, 8042-8180, 8191-8246, 8248-8700, 9020, 9071

C510 Labium majus
C511 Labium minus
C512 Clitoris
C518 Overlapping lesion of vulva
C519 Vulva, NOS

Note 1: The following sources were used in the development of this schema

  • SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)
  • SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)
  • Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx
  • Chapter 50 Vulva, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.

Note 2: See the following schemas for the listed histologies

  • 8041, 8190, 8247: Merkel Cell Skin
  • 8710-8714, 8800-8803, 8810-8921, 8932-8934, 8940-8990, 9000-9016, 9030-9043, 9045-9070, 9072-9138, 9141-9230, 9240-9580, 9582: Soft Tissue Abdomen and Thoracic
  • 8720-8790: Melanoma Skin
  • 8804-8806, 8930-8931, 8991, 9044, 9231, 9581: Soft Tissue Rare
  • 8935-8936: GIST
  • 8992: Soft Tissue Other
  • 9140: Kaposi Sarcoma
  • 9700-9701: Mycosis Fungoides

Note 3: Basal and squamous cell carcinomas of the skin of the vulva are coded to C519 and are reportable; basal and squamous carcinomas of the skin of the perineum would be coded to C445 and would not be reportable.

Data Items

Name Default Value Used for Staging NAACCR Item Required By Metadata
Year of Diagnosis <BLANK> No NAACCR #390
dateOfDiagnosis
None
Primary Site <BLANK> Yes NAACCR #400
primarySite
None
Histology <BLANK> Yes NAACCR #522
histologicTypeIcdO3
None
Behavior <BLANK> Yes NAACCR #523
behaviorCodeIcdO3
None
Tumor Size Clinical <BLANK> No NAACCR #752
tumorSizeClinical
None
Tumor Size Pathological <BLANK> No NAACCR #754
tumorSizePathologic
None
Tumor Size Summary 999 Yes NAACCR #756
tumorSizeSummary
None
Regional Nodes Positive 99 No NAACCR #820
regionalNodesPositive
None
Regional Nodes Examined 99 No NAACCR #830
regionalNodesExamined
None
LVI 9 No NAACCR #1182
lymphVascularInvasion
None
RX Summ Surgery/Radiation Sequence <BLANK> No NAACCR #1380
rxSummSurgRadSeq
None
RX Summ Systemic/Surgery Sequence <BLANK> No NAACCR #1639
rxSummSystemicSurSeq
None
EOD Primary Tumor 999 Yes NAACCR #772
eodPrimaryTumor
None
EOD Regional Nodes 999 Yes NAACCR #774
eodRegionalNodes
None
EOD Mets 00 Yes NAACCR #776
eodMets
None
SS2018 <BLANK> No NAACCR #764
summaryStage2018
None
Grade Clinical 9 No NAACCR #3843
gradeClinical
CCCR/Canada
COC
NPCR
SEER
SSDI
Grade Pathological 9 No NAACCR #3844
gradePathological
CCCR/Canada
COC
NPCR
SEER
SSDI
Grade Post Therapy Clin (yc) <BLANK> No NAACCR #1068
gradePostTherapyClin
COC
NPCR
SEER
SSDI
Grade Post Therapy Path (yp) <BLANK> No NAACCR #3845
gradePostTherapy
CCCR/Canada
COC
NPCR
SEER
SSDI
FIGO Stage 98 No NAACCR #3836
figoStage
COC
SEER
SSDI
LN Status Femoral-Inguinal, Para-aortic, Pelvic 8 No NAACCR #3884
lnStatusFemorInguinParaaortPelv
None SSDI 2018–2021
LN Status: Femoral-Inguinal 8 No NAACCR #3959
lnStatusFemoralInguinal
None SSDI
Lymph Nodes Assessment Method Femoral-Inguinal 8 No NAACCR #3871
lnAssessMethodFemoralInguinal
COC
SEER (RC)
SSDI
LN Status: Pelvic 8 No NAACCR #3957
lnStatusPelvic
None SSDI
Lymph Nodes Assessment Method Pelvic 8 No NAACCR #3873
lnAssessMethodPelvic
COC
SEER (RC)
SSDI
Lymph Nodes Laterality 8 No NAACCR #3881
lnLaterality
COC
SEER
SSDI